PROBLEMAS QUE INTEGRAN CONTENIDOS. VÍA PARA LA ACTIVACIÓN DEL APRENDIZAJE.

The objective of this article is to offer an explanation about how the integration of contents can contribute to the activation of the teaching-learning process of the students. Inadequacies in the active role in learning the contents of the subject were found in students of the Chemical Education career. During the research, theoretical methods are used that enable the interpretation of the topic, as well as empirical methods such as participant observation, pre-experiment, study of products of the pedagogical process and pedagogical tests. As a result, a teaching material that includes a methodology was developed; the understanding of the content is facilitated and encourages the search for solutions to exercises posed with different degrees of difficulty. In the pre - experiment, a sample of six second - year students from the Chemical Education program at the University of Camagüey was used. These results evidenced greater motivation of the students for the content of the subject, more academic performance and application of what was learned in professional practice and in their daily life.  El objetivo del presente artículo es ofrecer una explicación acerca de cómo la integración de contenidos puede contribuir a la activación del proceso de enseñanza – aprendizaje de los estudiantes. Se constató en estudiantes de la carrera Educación Química insuficiencias en el papel activo en el aprendizaje de contenidos de la asignatura. Durante la investigación se emplean métodos teóricos que posibilitan la interpretación del tema, así como métodos empíricos tales como observación participante, pre-experimento, estudio de productos del proceso pedagógico y pruebas pedagógicas. Como resultado, se elaboró un material docente que incluye una metodología; se facilita así, la comprensión del contenido, y propicia la búsqueda de soluciones a ejercicios planteados con diferentes grados de dificultad. En el pre – experimento se empleó una muestra de seis estudiantes de segundo año de la carrera Educación Química de la Universidad de Camagüey. Dichos resultados evidenciaron mayor motivación de los estudiantes por el contenido del tema, más rendimiento académico y aplicación de lo aprendido en la práctica profesional y en su vida cotidiana

A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future

© 2020 Pérez de Llano et al.Chronic airflow obstruction affects a wide range of airway diseases, the most frequent of which are asthma, COPD, and bronchiectasis; they are clearly identifiable in their extremes, but quite frequently overlap in some of their pathophysiological and clinical characteristics. This has generated the description of new mixed or overlapping disease phenotypes with no clear biological grounds. In this special article, a group of experts provides their perspective and proposes approaching the treatment of chronic airway disease (CAD) through the identification of a series of therapeutic goals (TG) linked to treatable traits (TT) – understood as clinical, physiological, or biological characteristics that are quantifiable using biomarkers. This therapeutic approach needs validating in a clinical trial with the strategy of identification of TG and treatment according to TT for each patient independently of their prior diagnosis

Resumen ejecutivo del documento de consenso sobre el manejo de la patología renal en pacientes con infección por VIH

El objetivo de este documento es actualizar las recomendaciones sobre la evaluación y el manejo de la afectación renal en pacientes con infección por el VIH del año 2010. La función renal debe monitorizarse en todos los pacientes e incluir la medida de la concentración sérica de creatinina, la estimación del filtrado glomerular (ecuación CKD-EPI), la medida del cociente proteína/creatinina en orina y un sedimento urinario. El estudio básico de la función tubular ha de incluir la concentración sérica de fosfato y la tira reactiva de orina (glucosuria). En ausencia de alteraciones, el cribado será anual. En pacientes tratados con tenofovir o con factores de riesgo para el desarrollo de enfermedad renal crónica (ERC), se recomienda una evaluación más frecuente. Se debe evitar el uso de antirretrovirales potencialmente nefrotóxicos en pacientes con ERC o factores de riesgo para evitar su progresión. También se revisan las indicaciones de la biopsia renal, cuándo enviar el paciente al nefrólogo y las indicaciones, evaluación y manejo del paciente en diálisis o del trasplante renal

El fenómeno del dopaje desde la perspectiva de las Ciencias Sociales Odile

En este libro se recoge una selección de las comunicaciones presentadas en el IV Congreso Internacional ‘Deporte, Dopaje y Sociedad’ que se celebró en Madrid del 26 de febrero al 1 de marzo de 2014 y que fue organizado conjuntamente por la Universidad Politécnica de Madrid y la Agencia Española de Protección de la Salud en el Deporte. Los textos están escritos en español, francés e inglés y abordan el estudio del fenómeno del dopaje desde el ámbito especifico de las Ciencias Humanas y Sociales a través de disciplinas como Historia, Derecho, Sociología, Psicología, Economía, Ciencias de la Información y otras disciplinas relacionadas

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

(1) Scant information is available concerning the characteristics that may favour the acquisition of COVID-19 in patients with inflammatory bowel disease (IBD). Therefore, the aim of this study was to assess these differences between infected and noninfected patients with IBD. (2) This nationwide case-control study evaluated patients with inflammatory bowel disease with COVID-19 (cases) and without COVID-19 (controls) during the period March-July 2020 included in the ENEIDA of GETECCU. (3) A total of 496 cases and 964 controls from 73 Spanish centres were included. No differences were found in the basal characteristics between cases and controls. Cases had higher comorbidity Charlson scores (24% vs. 19%; p = 0.02) and occupational risk (28% vs. 10.5%; p < 0.0001) more frequently than did controls. Lockdown was the only protective measure against COVID-19 (50% vs. 70%; p < 0.0001). No differences were found in the use of systemic steroids, immunosuppressants or biologics between cases and controls. Cases were more often treated with 5-aminosalicylates (42% vs. 34%; p = 0.003). Having a moderate Charlson score (OR: 2.7; 95%CI: 1.3-5.9), occupational risk (OR: 2.9; 95%CI: 1.8-4.4) and the use of 5-aminosalicylates (OR: 1.7; 95%CI: 1.2-2.5) were factors for COVID-19. The strict lockdown was the only protective factor (OR: 0.1; 95%CI: 0.09-0.2). (4) Comorbidities and occupational exposure are the most relevant factors for COVID-19 in patients with IBD. The risk of COVID-19 seems not to be increased by immunosuppressants or biologics, with a potential effect of 5-aminosalicylates, which should be investigated further and interpreted with caution

Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019

Altres ajuts: Spanish AIDS Research Network; European Funding for Regional Development (FEDER).Objectives: We assessed the prevalence of anti-hepatitis C virus (HCV) antibodies and active HCV infection (HCV-RNA-positive) in people living with HIV (PLWH) in Spain in 2019 and compared the results with those of four similar studies performed during 2015-2018. Methods: The study was performed in 41 centres. Sample size was estimated for an accuracy of 1%. Patients were selected by random sampling with proportional allocation. Results: The reference population comprised 41 973 PLWH, and the sample size was 1325. HCV serostatus was known in 1316 PLWH (99.3%), of whom 376 (28.6%) were HCV antibody (Ab)-positive (78.7% were prior injection drug users); 29 were HCV-RNA-positive (2.2%). Of the 29 HCV-RNA-positive PLWH, infection was chronic in 24, it was acute/recent in one, and it was of unknown duration in four. Cirrhosis was present in 71 (5.4%) PLWH overall, three (10.3%) HCV-RNA-positive patients and 68 (23.4%) of those who cleared HCV after anti-HCV therapy (p = 0.04). The prevalence of anti-HCV antibodies decreased steadily from 37.7% in 2015 to 28.6% in 2019 (p < 0.001); the prevalence of active HCV infection decreased from 22.1% in 2015 to 2.2% in 2019 (p < 0.001). Uptake of anti-HCV treatment increased from 53.9% in 2015 to 95.0% in 2019 (p < 0.001). Conclusions: In Spain, the prevalence of active HCV infection among PLWH at the end of 2019 was 2.2%, i.e. 90.0% lower than in 2015. Increased exposure to DAAs was probably the main reason for this sharp reduction. Despite the high coverage of treatment with direct-acting antiviral agents, HCV-related cirrhosis remains significant in this population

Correction : Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885

The authors wish to make the following corrections to this paper [...]